These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33222150)

  • 21. [MATERNAL-FETAL INCOMPATIBILITY IN THE ABO AND RH HR SYSTEMS].
    MONGEAMADOR R; LORIACORTES R; VARGASSANDINO C; CHAVESVILLALOBOS E
    Rev Med Costa Rica; 1964 Aug; 21():317-26. PubMed ID: 14211181
    [No Abstract]   [Full Text] [Related]  

  • 22. What is the best predictor of the severity of ABO-haemolytic disease of the newborn?
    Brouwers HA; Overbeeke MA; van Ertbruggen I; Schaasberg W; Alsbach GP; van der Heiden C; van Leeuwen EF; Stoop JW; Engelfriet CP
    Lancet; 1988 Sep; 2(8612):641-4. PubMed ID: 2901516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABO hemolytic disease of the fetus and newborn: an iatrogenic complication of heterologous assisted reproductive technology-induced pregnancy.
    Zuppa AA; Cardiello V; Lai M; Cataldi L; D'Andrea V; Romagnoli C
    Transfusion; 2010 Oct; 50(10):2102-4. PubMed ID: 20492611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [ABO incompatibility and newborn haemolytic disease: two cases with major erythroblastosis].
    Palleau S; Le Tourneau C; Jrad I; Andreux JP; Gouin I; Siguret V
    Ann Biol Clin (Paris); 2004; 62(3):344-8. PubMed ID: 15217770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement is not activated in ABO-haemolytic disease of the newborn.
    Brouwers HA; Overbeeke MA; Huiskes E; Bos MJ; Ouwehand WH; Engelfriet CP
    Br J Haematol; 1988 Mar; 68(3):363-6. PubMed ID: 3258530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical consequences of the extremely rare anti-PP1Pk isoantibodies in pregnancy: a case series and review of the literature.
    Di Ciaccio P; Cutts B; Alahakoon TI; Dennington PM; Soo LA; Curnow J
    Vox Sang; 2021 May; 116(5):591-600. PubMed ID: 33326620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 28. Direct antiglobulin reaction in ABO-haemolytic disease of the newborn.
    Romano EL; Hughes-Jones NC; Mollison PL
    Br Med J; 1973 Mar; 1(5852):524-6. PubMed ID: 4540300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. THE FREQUENCY OF ABO-INCOMPATIBLE COMBINATIONS IN RELATION TO MATERNAL RHESUS ANTIBODY VALUES IN RH IMMUNIZED WOMEN.
    VOS GH
    Am J Hum Genet; 1965 May; 17(3):202-11. PubMed ID: 14295490
    [No Abstract]   [Full Text] [Related]  

  • 30. Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years.
    Matteocci A; De Rosa A; Buffone E; Pierelli L
    Transfus Med; 2019 Jun; 29(3):197-201. PubMed ID: 29369480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and titre of ABO haemolysin antibodies in pregnant Nigerian women.
    Usanga EA; Akwiwu JO
    East Afr Med J; 1990 Jun; 67(6):437-41. PubMed ID: 2279474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [PRACTICAL TRENDS IN CASES OF RH AND ABO MATERNO-FETAL INCOMPATIBILITY].
    MITTIGA M; MORINI A
    Rass Clin Ter; 1964; 63():158-164. PubMed ID: 14163277
    [No Abstract]   [Full Text] [Related]  

  • 33. ABO BLOOD GROUP SYSTEM AND ITS RELATIONSHIP TO HEMOLYTIC DISEASE.
    FREDA VJ; CARTER BA
    Clin Obstet Gynecol; 1964 Dec; 10():968-84. PubMed ID: 14234049
    [No Abstract]   [Full Text] [Related]  

  • 34. Red cell membrane protein in antibody induced haemolytic anaemia.
    Gomperts ED; Metz J; Zail SS
    Br J Haematol; 1973 Oct; 25(4):421-8. PubMed ID: 4796239
    [No Abstract]   [Full Text] [Related]  

  • 35. [Testing of neonate blood in establishing the diagnosis of hemolytic disease in the newborn according to ABO blood group incompatibility].
    Morawska A
    Przegl Lek; 1969; 25(10):684-7. PubMed ID: 5307842
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
    Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
    Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Haemolytic disease of the newborn (fetus) (author's transl)].
    Fischer K; Poschmann A
    Immun Infekt; 1976 Dec; 4(6):249-60. PubMed ID: 828142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "ABO hemolytic disease".
    Smith DW; Stevenson DK
    Clin Pediatr (Phila); 1986 Feb; 25(2):116. PubMed ID: 3943260
    [No Abstract]   [Full Text] [Related]  

  • 39. Secretor status of blood group O mothers is associated with development of ABO haemolytic disease in the newborn.
    Krog GR; Lorenzen H; Clausen FB; Dziegiel MH
    Vox Sang; 2023 May; 118(5):402-406. PubMed ID: 36896479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.
    Hadley AG
    Transpl Immunol; 2002 Aug; 10(2-3):191-8. PubMed ID: 12216949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.